DWTX — Dogwood Therapeutics Share News
0.000.00%
U.S. STOCKS ON THE MOVE-Verizon Communications, Home Depot, Catalent
U.S. STOCKS ON THE MOVE-Oramed, Fisker, Blue Bird
U.S. STOCKS ON THE MOVE-Sarepta Therapeutics, C3.ai, Tapestry
Virios rises on submission of toxicology reports for chronic disease therapy trial
Brief: Virios Therapeutics Announces Submission Of Final Toxicology Results
Virios Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Virios Therapeutics Announces Q1 2023 Financial Results
Virios Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Virios Therapeutics Gets Letter From Nasdaq, That Co Has Until Oct 30, To Regain Compliance With Minimum Bid Price Requirement
U.S. STOCKS ON THE MOVE-PepsiCo, McDonald's, Dow
Brief: Virios Therapeutics Announces Initial FDA Feedback For Lead Drug Candidate Trial
Virios up on FDA's positive feedback on lead drug candidate
Brief: Virios Therapeutics Inc Says Believe That Company Has Capital To Support General And Administrative Operations Into Q2 Of 2024
Virios Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Virios Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results
Virios Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Virios Therapeutics To Report Third Quarter 2022 Financial Results
U.S. STOCKS ON THE MOVE-Ford, Pagaya Technologies, Nike
U.S. STOCKS ON THE MOVE-Peloton, Pagaya Technologies, AVROBIO, Ford